Braze Inc vs McKesson Corporation — how do they compare? Braze Inc trades at $27.76 (market cap $3.18B), while McKesson Corporation trades at $894.99 (market cap $105.14B). The key difference: McKesson Corporation is far larger — about 33.1× Braze Inc's market cap, and McKesson Corporation pays a 0.42% dividend while Braze Inc pays none. Which is the better fit depends on your goals.
| BRZE | MCK | |
|---|---|---|
Market Cap | $3.18B | $105.14B |
Sector | Technology | Health |
52-Week High | $36.19 | $995.69 |
52-Week Low | $15.79 | $659.01 |
Enterprise Value | $2.87B | $111.67B |
Dividend Yield | — | 0.42% |
Trailing returns across standard periods
Braze Inc is a customer engagement platform that powers customer-centric interactions between consumers and brands. The company provides solutions for Retail & E-commerce, Media & Entertainment, Financial Services, and Travel & Hospitality related industries.
Read more on BRZE →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →